Regeneron Pharmaceuticals (MEX:REGN) Buildings And Improvements : MXN0 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Regeneron Pharmaceuticals Buildings And Improvements?

Regeneron Pharmaceuticals's quarterly buildings and improvements increased from Sep. 2024 (MXN0 Mil) to Dec. 2024 (MXN53,666 Mil) but then declined from Dec. 2024 (MXN53,666 Mil) to Mar. 2025 (MXN0 Mil).

Regeneron Pharmaceuticals's annual buildings and improvements declined from Dec. 2022 (MXN44,256 Mil) to Dec. 2023 (MXN41,130 Mil) but then increased from Dec. 2023 (MXN41,130 Mil) to Dec. 2024 (MXN53,666 Mil).

Regeneron Pharmaceuticals Buildings And Improvements Historical Data

The historical data trend for Regeneron Pharmaceuticals's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regeneron Pharmaceuticals Buildings And Improvements Chart

Regeneron Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

37,617.76

42,843.49

44,255.92

41,130.30

53,665.89

Regeneron Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															-	-	-	53,665.89	-

Regeneron Pharmaceuticals Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Regeneron Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (MEX:REGN) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

REGN:USA 0R2M:UK RGO:Germany RGO:Germany REGN34:Brazil REGN:Austria

Address

777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707

Website

https://www.regeneron.com

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).